Friday, November 22, 2024
Print Current Day:
|
|
SESSION 79 SCHEDULE | |
Friday
SESSION 79:
PROGRESS IN THE PREVENTION AND TREATMENT OF SPINAL CORD ISCHEMIA (SCI) ASSOCIATED WITH THE TREATMENT OF THORACIC, THORACOABDOMINAL AND COMPLEX ABDOMINAL ANEURYSMS
Location: Grand Ballroom East, 3rd Floor
Moderators:Germano C.G. Melissano, MD / Christian D. Etz, MD, PhD / Adam Beck, MD |
|
x | |
6:40 AM - 6:45 AM | New Experimental Work In Avoiding SCI After TAAA Repair: How Can A Sheep Model Of TEVAR Be Helpful |
Presenter(s):Hamdy Awad, MD Location: Grand Ballroom East, 3rd Floor |
|
6:46 AM - 6:51 AM | With Complex AAAs And Type IV TAAAs, The Incidence Of SCI Is 3 Times Greater With Endovascular Repairs Than Open Repairs: Why Is This A Controversial Finding And How Can It Be So |
Presenter(s):George Geroulakos, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
6:52 AM - 6:57 AM | Prediction Of Spinal Cord Ischemia With AI After Aortic Procedures: Combinations Of Anatomic Features Accurately Predict Risk |
Presenter(s):Kak Khee Yeung, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
6:58 AM - 7:03 AM | What Is The Muenster Strategy To Avoid SCI After F/B/EVAR For TAAA: What Is The Proof That It Works |
Presenter(s):Martin J. Austermann, MD Location: Grand Ballroom East, 3rd Floor |
|
7:04 AM - 7:09 AM | How To Use Motor Evoked Potentials (MEPs) To Decrease The Incidence Of SCI After Open And Endo TAAA Repairs: What Else Is Important |
Presenter(s):James H... Black, III, MD Location: Grand Ballroom East, 3rd Floor |
|
7:10 AM - 7:15 AM | Role Of Direct Segmental Artery Revascularization To Prevent SCI After Endovascular TAAA Repairs: When And How To Do It |
Presenter(s):Sukgu Han, MD Location: Grand Ballroom East, 3rd Floor |
|
7:16 AM - 7:21 AM | Current Strategies To Minimize SCI With TAAA Repairs (Endo And Open) By Improving The Intraspinal Collateral Arterial Network: Status Of Intercostal Embolization As Preconditioning To Prevent Ischemia (MIS2ACE): Progress Of The PAPA-ARTIS RCT |
Presenter(s):Christian D. Etz, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
7:22 AM - 7:27 AM | Extensive Single Center Clinical Experience With Intercostal Coil Embolization (MIS2ACE) To Prevent SCI With Endovascular TAAA Repair: How And When To Do It: Why We Still Need An RCT |
Presenter(s):Daniela Branzan, MD / Andrej Schmidt, MD Location: Grand Ballroom East, 3rd Floor |
|
7:28 AM - 7:33 AM | Why Cerebrospinal Fluid (CSF) Drainage To Decrease SCI With TAAA Repair Is Not A Benign Procedure: When To Use It And When Not |
Presenter(s):Gustavo S. Oderich, MD, FACS Location: Grand Ballroom East, 3rd Floor |
|
7:34 AM - 7:39 AM | Prevention Of SCI After Endovascular TAAA Repairs: Lessons Learned From The US Aortic Research Consortium (ARC) |
Presenter(s):Adam Beck, MD / Mark A. Farber, MD / Andres Schanzer, MD Location: Grand Ballroom East, 3rd Floor |
|
7:40 AM - 7:45 AM | Shifts In Prevention Protocols For SCI During Open And Endovascular TAAA Repairs: What Is Agreed On And What Remains Controversial |
Presenter(s):Germano C.G. Melissano, MD / Roberto L.V. Chiesa, MD Location: Grand Ballroom East, 3rd Floor |
|
7:46 AM - 7:54 AM | Panel Discussion |
END OF SESSION 79 | |
SESSION 80 SCHEDULE | |
Friday
SESSION 80:
NEW DEVELOPMENTS IN THE TREATMENT OF CAROTID STENOSIS: UPDATE ON MESH COVERED STENTS AND TCAR (TRANSCERVICAL CAROTID ARTERY REVASCULARIZATION)
Location: Grand Ballroom East, 3rd Floor
Moderators:Klaus D. Mathias, MD / Marc L. Schermerhorn, MD / Bruce A. Perler, MD, MBA |
|
x | |
7:54 AM - 7:59 AM | Carotid Webs: An Important Etiology Of Devastating Strokes Especially In Young Women: How Should They Be Diagnosed And Treated |
Presenter(s):Bruce A. Perler, MD, MBA Location: Grand Ballroom East, 3rd Floor |
|
MESH COVERED STENTS | |
8:00 AM - 8:05 AM | Long-Term Results Of Micromesh Stents Show Their Value In Carotid Artery Stenting (CAS): Are There Limitations: Do The Differences In The 3 Micromesh Stents Matter |
Presenter(s):Max Amor, MD / D. Christopher Metzger, MD Location: Grand Ballroom East, 3rd Floor |
|
8:06 AM - 8:11 AM Power Point Presentation with Synched Audio |
When You Can Do All, How To Decide Between CEA, TCAR And TFCAS: Will Mesh Covered Stents Like CGuard Make A Difference |
Presenter(s):Adnan H. Siddiqui, MD, PhD / L. Nelson Hopkins, MD Location: Grand Ballroom East, 3rd Floor |
|
8:12 AM - 8:17 AM | Outcome Of TCAR Combined With A Mesh-Covered Stent (CGuard From InspireMD): The Best Of All Worlds: What Is The Proof |
Presenter(s):Ralf R. Kolvenbach, MD Location: Grand Ballroom East, 3rd Floor |
|
8:18 AM - 8:23 AM | Update On All Trial Results With CGuard And CGuard Prime MicroMesh Covered Stents (InspireMD): Are They Making A Difference And Limitations With Transfemoral/Transradial CAS: Evidence Summary And Long-Term Outcomes |
Presenter(s):Piotr Musialek, MD, DPhil / D. Christopher Metzger, MD / Stefan Mueller-Huelsbeck, MD Location: Grand Ballroom East, 3rd Floor |
|
8:24 AM - 8:29 AM | US Studies And Status Of The CGuard And CGuard Prime MicroMesh Stents: Can They Be Used In TCAR And Are They Making A Difference |
Presenter(s):Patrick J. Geraghty, MD Location: Grand Ballroom East, 3rd Floor |
|
8:30 AM - 8:35 AM | Latest Real-World Results Of >2,000 Patients Treated With The Roadsaver (Terumo) Dual-Layer Micromesh Carotid Stent |
Presenter(s):Stefan Mueller-Huelsbeck, MD Location: Grand Ballroom East, 3rd Floor |
|
8:36 AM - 8:42 AM | Panel Discussion |
TCAR RELATED TOPICS | |
8:42 AM - 8:47 AM | Update On Comparative Performance And Risks Of TCAR, Transfemoral CAS (TFCAS) And CEA With > 50K TCAR, 25K TFCAS, And 100K CEA: This Population Based Study Shows That CEA Is Better Than TCAR Which Is Better Than TFCAS |
Presenter(s):Marc L. Schermerhorn, MD / Mahmoud B. Malas, MD, MHS Location: Grand Ballroom East, 3rd Floor |
|
8:48 AM - 8:53 AM | Is TCAR Ready To Replace CEA: What About The Clinical Results To Date: What About The Impact Of Clever Marketing: How Will We Find Out |
Presenter(s):Bruce A. Perler, MD, MBA Location: Grand Ballroom East, 3rd Floor |
|
8:54 AM - 8:59 AM | DEBATE: CEA Versus TCAR In A Single Center Propensity Matched Study: The Outcomes Of The Two Treatments Are Comparable At 30 Days But TCAR Has A Higher Mortality At 2 Years |
Presenter(s):Ali F. AbuRahma, MD / Zach AbuRahma, DO Location: Grand Ballroom East, 3rd Floor |
|
9:00 AM - 9:05 AM | DEBATE: Not So: TCAR Like TFCAS Has Durable Effectiveness Without Increased Mortality At 2 Years And Beyond |
Presenter(s):Sumaira Macdonald, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
9:06 AM - 9:11 AM | Favorable 30-Day Results Of TCAR In Good Risk Symptomatic And Asymptomatic Patients: Late Breaking Trial Results From ROADSTER 3 Shows That The Stroke, Death And MI Rates Are Lower Than In High Risk Patients |
Presenter(s):Marc L. Schermerhorn, MD Location: Grand Ballroom East, 3rd Floor |
|
9:12 AM - 9:17 AM | TCAR Is Safe In Recently Symptomatic Patients And Those With Contralateral Carotid Occlusions: Why TCAR Should Be The Procedure Of Choice In These Conditions |
Presenter(s):Peter A. Schneider, MD Location: Grand Ballroom East, 3rd Floor |
|
9:18 AM - 9:23 AM | Panel Discussion |
9:24 AM - 9:34 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 80 | |
SESSION 81 SCHEDULE | |
Friday
SESSION 81:
MORE CAROTID HOT TOPICS RELATED TO TCAR, CAS AND EFFECTS OF INTERVENTIONS ON COGNITIVE FUNCTION
Location: Grand Ballroom East, 3rd Floor
Moderators:Thomas G. Brott, MD / Peter L. Faries, MD, FACS / Michael B. Silva, Jr., MD |
|
x | |
9:35 AM - 9:40 AM | Comparative Cost Effectiveness Of TCAR, CEA, TFCAS: CEA Is More Cost Effective Than TCAR And TCAR Is More Cost Effective Than TFCAS |
Presenter(s):Mohammad H. Eslami, MD, MPH Location: Grand Ballroom East, 3rd Floor |
|
9:41 AM - 9:46 AM | Intracranial Angiography During TCAR: Why It Can Be Valuable And How To Do It In View Of Flow Reversal |
Presenter(s):Peter L. Faries, MD, FACS Location: Grand Ballroom East, 3rd Floor |
|
9:47 AM - 9:52 AM | Best Device Selection For CAS: What Stent Type And Design, What Type Of Cerebral Protection, What Approach And Delivery System: A Review Of The Evidence |
Presenter(s):Carlo Setacci, MD / Francesco Setacci, MD Location: Grand Ballroom East, 3rd Floor |
|
9:53 AM - 9:58 AM | Comparison Of SVS Versus ESVS Carotid Guidelines For Treatment Of Asymptomatic Carotid Artery Stenosis: What Is Known For Sure And What Remains Controversial |
Presenter(s):Ali F. AbuRahma, MD Location: Grand Ballroom East, 3rd Floor |
|
9:59 AM - 10:04 AM | Management Of Anticoagulants And Antiplatelet Therapy In TCAR Patients |
Presenter(s):Michael C. Stoner, MD Location: Grand Ballroom East, 3rd Floor |
|
CAROTID STENOSIS AND COGNITIVE FUNCTION | |
10:05 AM - 10:10 AM | Preservation Of Cognition: The New Role For Carotid Artery Interventions For Asymptomatic Disease: Will CREST 2 Confirm Or Deny Its Importance: Findings To Date |
Presenter(s):Wesley S. Moore, MD / Brajesh K. Lal, MD / Thomas G. Brott, MD Location: Grand Ballroom East, 3rd Floor |
|
10:11 AM - 10:16 AM | DEBATE: Carotid Intervention Improves Cognitive Function Of Patients With Severe Asymptomatic Carotid Stenosis (ACS): What About In Octogenarians: Should More Or Fewer ACS Patients Undergo Invasive Treatment |
Presenter(s):Wei Zhou, MD Location: Grand Ballroom East, 3rd Floor |
|
10:17 AM - 10:22 AM Power Point Presentation with Synched Audio |
DEBATE: Not So Fast: There Is Still Great Doubt That Eliminating ACS Improves Cognitive Function: It Should Not Be A Reason For Treating More ACS Patients |
Presenter(s):Anne L. Abbott, MD, PhD, FRACP Location: Grand Ballroom East, 3rd Floor |
|
10:23 AM - 10:30 AM | Panel Discussion |
END OF SESSION 81 | |
SESSION 82 SCHEDULE | |
Friday
SESSION 82:
MORE CAROTID RELATED NEW DEVELOPMENT TOPICS RELATED TO TCAR, CAS AND CEA, NEW DEVICES, MESH COVERED STENTS, MINI-INCISION CEA, SIGNIFICANCE OF DW MRI DEFECTS, TIMING OF TREATMENT, MEDICAL TREATMENT AND DEALING WITH DISTAL (HIGH) CAROTID LESIONS
Location: Grand Ballroom East, 3rd Floor
Moderators:Richard J. Powell, MD / Wei Zhou, MD / Frank J. Veith, MD |
|
x | |
10:30 AM - 10:35 AM Power Point Presentation with Synched Audio |
Transradial CAS Using Novel Low-Profile Double-Mesh Stents (Roadsaver, Terumo): Results And Technical Tips |
Presenter(s):Andrea Kahlberg, MD Location: Grand Ballroom East, 3rd Floor |
|
10:36 AM - 10:41 AM | Selecting Patients For Carotid Intervention Is Getting Harder: Candidates Are Older (And Sicker), Anatomic Imaging Is Not Standardized, Medical Therapy Is Improving, More Options For Intervention Exist And Cries For Non-Operative Management Are Getting Louder: Is Consensus Even Possible |
Presenter(s):Reese A. Wain, MD Location: Grand Ballroom East, 3rd Floor |
|
SIGNIFICANCE OF SMALL DW MRI DEFECTS AFTER CEA/CAS | |
10:42 AM - 10:47 AM | DEBATE: Silent DWI MRI Brain Lesions (Small Infarcts) After CEA/CAS Don’t Matter |
Presenter(s):Thomas G. Brott, MD Location: Grand Ballroom East, 3rd Floor |
|
10:48 AM - 10:53 AM | DEBATE: Not So: Silent Brain Infarcts (DW MRI Defects) After CEA/CAS Really Matter And Affect Cognitive Changes: The Size And Number Of DW MRI Defects Are Critical |
Presenter(s):Wei Zhou, MD Location: Grand Ballroom East, 3rd Floor |
|
10:54 AM - 10:59 AM | Value Of Lithotripsy (Shockwave) For CAS In Heavily Calcified Lesions: How To Do It Safely And Technical Tips: Limitations And Precautions |
Presenter(s):Max Amor, MD Location: Grand Ballroom East, 3rd Floor |
|
11:00 AM - 11:05 AM | Minimal Incision CEA (MICE) Versus TCAR: Technical Tips For MICE, Cost Effectiveness, Advantages And Limitations Of Both |
Presenter(s):Enrico Ascher, MD Location: Grand Ballroom East, 3rd Floor |
|
11:06 AM - 11:11 AM | For Symptomatic Carotid Stenosis Invasive Treatment (TFCAS, CEA, TCAR) On Weekends Is More Risky: This Is Especially True For TFCAS Which Probably Should Not Be Performed On Weekends |
Presenter(s):Heepeel Chang, MD Location: Grand Ballroom East, 3rd Floor |
|
11:12 AM - 11:18 AM | Panel Discussion |
11:18 AM - 11:23 AM | What Is The Best Medical Treatment For Patients With Carotid Stenosis (Asymptomatic And Symptomatic): Can High Risk Plaques Be Made Low Risk And Smaller: All Stroke Patients Should Be On Statins Because They Markedly Decrease Recurrent Stroke And Mortality Rates |
Presenter(s):J. David Spence, MD Location: Grand Ballroom East, 3rd Floor |
|
11:24 AM - 11:29 AM | Technical Tips And Maneuvers To Make Treatment Of High Carotid Lesions Safe And Relatively Simple |
Presenter(s):Richard J. Powell, MD Location: Grand Ballroom East, 3rd Floor |
|
11:30 AM - 11:35 AM | What Are The Real Risk Factors For CEA, TFCAS And TCAR: Why Has CMS Gotten Their Risk Factors Wrong And How Have They Messed Up Their Reimbursement Incentives |
Presenter(s):Mahmoud B. Malas, MD, MHS Location: Grand Ballroom East, 3rd Floor |
|
TIMING OF CAROTID INTERVENTIONS AFTER SYMPTOM ONSET | |
11:36 AM - 11:41 AM | When Is Urgent (Within 48 Hours) CEA Or CAS Fairly Indicated After A Stroke: How Does Use Of tPA Influence Indications And Neurologic Outcomes In This Setting |
Presenter(s):Hernan A. Bazan, MD, DFSVS, FACS Location: Grand Ballroom East, 3rd Floor |
|
11:42 AM - 11:47 AM | When Is It Reasonable To Perform CEA Within 48 Hours After Stroke Symptoms Starts: Under What Conditions And What Precautions Should Be Taken |
Presenter(s):R. Clement Darling III, MD Location: Grand Ballroom East, 3rd Floor |
|
11:48 AM - 11:53 AM | With Crescendo TIAs And Thrombus Overlying A Plaque What Is The Best Invasive Treatment And When Should It Be Performed |
Presenter(s):Domenico Valenti, DMChir, PhD, FRCS, FRCS(Ed), FEBVS Location: Grand Ballroom East, 3rd Floor |
|
11:54 AM - 12:00 PM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break – Rhinelander Gallery, 2nd Floor Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 82 | |
SESSION 83 SCHEDULE | |
Friday
SESSION 83:
MORE HOT CAROTID AND SUBCLAVIAN TOPICS: UPDATES ON KEY CAROTID RCTs
Location: Grand Ballroom East 3rd Floor
Moderators:Brajesh K. Lal, MD / Wesley S. Moore, MD / Glenn M. LaMuraglia, MD |
|
x | |
1:00 PM - 1:05 PM | Lipid Management For High Risk Carotid Lesions: Statins, Ezetimibe, PCSK9 And What Else: Should LDL-C Be Monitored |
Presenter(s):Christos D. Liapis, MD Location: Grand Ballroom East 3rd Floor |
|
UPDATE ON CAROTID RCTs | |
1:06 PM - 1:11 PM | Update On CREST 2: CEA Versus Best Medical Treatment (BMT) And CAS Versus BMT For Asymptomatic Carotid Stenosis (ACS): Recruitment And Findings To Date: Why Not Present The 30-Day And 1-Year Results: If BMT Showed No Difference In Stroke And Death Rates With Those Of CAS Or CEA, Wouldn’t This Remove Justification For Invasive Treatment Of ACS Until A Benefit Was Shown |
Presenter(s):Thomas G. Brott, MD / Brajesh K. Lal, MD Location: Grand Ballroom East 3rd Floor |
|
1:12 PM - 1:17 PM | Why The Carotid RCTs Fail To Support The Recent CMS Expansion Of Reimbursement For CAS To Treat Asymptomatic Disease (ACS): Do The 5-Year SPACE-2 Results Suggest That Such Expanded Reimbursement Be Delayed Until CREST-2 Data Is In |
Presenter(s):Caitlin W. Hicks, MD, MS Location: Grand Ballroom East 3rd Floor |
|
1:18 PM - 1:23 PM | Why CREST-2 May Not Provide Any Valid Answers: Because Of Bad Patient Selection In CREST-2, And Because BMT May Not Be Optimal Without GLP-1 Agonists Which Decrease Stroke Rates: What Is The Evidence |
Presenter(s):Sumaira Macdonald, MD, PhD Location: Grand Ballroom East 3rd Floor |
|
1:24 PM - 1:29 PM | Update On ACST-2: This RCT Found That CEA And CAS For ACS Had Comparable Adverse Event Rates Up To 10 Years And Implied That Both Invasive Treatments Were Superior To Now Obsolete BMT |
Presenter(s):Alison Halliday, MS, FRCS / Richard Bulbulia, MA, MD, FRCS Location: Grand Ballroom East 3rd Floor |
|
1:30 PM - 1:35 PM | Not So Fast! ACST-2 – Like CREST – Has Flaws That Invalidate Their Conclusions: Invasive Therapies May NOT Be Better Than BMT: What Are These Flaws |
Presenter(s):J. David Spence, MD Location: Grand Ballroom East 3rd Floor |
|
1:36 PM - 1:41 PM | What Is The Proof That CAS Is Ever Indicated For ACS: The Evidence Does Not Yet Support It |
Presenter(s):Franco Grego, MD Location: Grand Ballroom East 3rd Floor |
|
1:42 PM - 1:47 PM | Panel Discussion |
1:48 PM - 1:53 PM | Consecutive Monocenter Results With CAS For Asymptomatic Carotid Stenosis (ACS): We Should Not Need An RCT: But Why We Will Still Do |
Presenter(s):Klaus D. Mathias, MD / Anna Zeller, MD Location: Grand Ballroom East 3rd Floor |
|
1:54 PM - 1:59 PM | The 2nd European Carotid Surgery Trial (ECST-2): What Will It Tell Us About Best Medical Therapy Versus Invasive Therapy And Progress To Date |
Presenter(s):Gert J. de Borst, MD, PhD Location: Grand Ballroom East 3rd Floor |
|
2:00 PM - 2:05 PM | When A Duplex Scan Detects Subclavian Steal, Symptomatic Or Asymptomatic, What Is The Natural History And How Should It Be Managed |
Presenter(s):Ali F. AbuRahma, MD Location: Grand Ballroom East 3rd Floor |
|
2:06 PM - 2:11 PM | DEBATE: Completion Imaging After CEA Is Unnecessary And Potentially Harmful |
Presenter(s):Ali F. AbuRahma, MD Location: Grand Ballroom East 3rd Floor |
|
2:12 PM - 2:17 PM | DEBATE: Not So: Completion Imaging (Angiography Or Duplex) After CEA Is Necessary And Helpful |
Presenter(s):Keith D. Calligaro, MD Location: Grand Ballroom East 3rd Floor |
|
2:18 PM - 2:23 PM | Panel Discussion |
END OF SESSION 83 | |
SESSION 84 SCHEDULE | |
Friday
SESSION 84:
MORE HOT CAROTID TOPICS: TREATMENT IN 2024 OF RECURRENT CAROTID STENOSIS; STROKES DURING CAROTID TREATMENT; CAROTID NEAR OCCLUSIONS; SILENT CORONARY ISCHEMIA IN CAROTID PATIENTS
Location: Grand Ballroom East, 3rd Floor
Moderators:Keith D. Calligaro, MD / Klaus D. Mathias, MD / Ali F. AbuRahma, MD |
|
x | |
2:24 PM - 2:29 PM | Most Recurrent Carotid Stenosis Is Benign: When Is Intervention Justified And What Intervention Should Be Used |
Presenter(s):Ashraf Mansour, MD Location: Grand Ballroom East, 3rd Floor |
|
2:30 PM - 2:35 PM | Current Best Treatment For Strokes Apparent During Or Right After CEA, CAS Or TCAR: Best Diagnostic Modalities And Treatments: Who Should Be Involved And What Skills Are Needed |
Presenter(s):Gert J. de Borst, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
2:36 PM - 2:41 PM | Can TCAR Be Helpful In The Management Of Carotid String Sign Lesions Or Near Occlusions Of The Internal Carotid Artery: When Is Its Use Justified, Advantage And Technical Tips |
Presenter(s):Animesh Rathore, MD Location: Grand Ballroom East, 3rd Floor |
|
2:42 PM - 2:47 PM | Advances In The Diagnosis And Treatment Of Near Total Occlusions And String Signs Of The Internal Carotid Artery (ICA) In Symptomatic And Asymptomatic Patients: How Are They Best Treated: What Do The Current Guidelines Say |
Presenter(s):Christos D. Liapis, MD Location: Grand Ballroom East, 3rd Floor |
|
2:48 PM - 2:53 PM | Optical Coherence Tomography (OCT) Proves CAS Is Rendered Safer Because Mesh Covered Stents Decrease Emboli: The Imaging Evidence And What It Shows About The Interaction Between Stent And Plaque |
Presenter(s):Carlo Setacci, MD / Francesco Setacci, MD Location: Grand Ballroom East, 3rd Floor |
|
2:54 PM - 2:59 PM | Silent Coronary Ischemia As Detected By FF+RCT Is Common In Carotid Stenosis Patients: Coronary Revascularization In Such Patients Decreases Mortality: When Should It Be Done – Before Or After Carotid Treatment |
Presenter(s):Christopher K. Zarins, MD / Dainis K. Krievins, MD Location: Grand Ballroom East, 3rd Floor |
|
3:00 PM - 3:05 PM | Technical Tips To Enable TCAR In Difficult Anatomic Circumstances Including Use Of A Prosthetic Conduit |
Presenter(s):Ashraf Mansour, MD Location: Grand Ballroom East, 3rd Floor |
|
3:06 PM - 3:11 PM | Compared To CEA, TCAR Improves Operating Room (OR) Throughout But Is More Costly: Tips To Improve OR Efficiency |
Presenter(s):Gregg S. Landis, MD Location: Grand Ballroom East, 3rd Floor |
|
3:12 PM - 3:19 PM | Panel Discussion |
3:19 PM - 3:30 PM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 84 | |
SESSION 85 SCHEDULE | |
Friday
SESSION 85:
UPDATED ENDOVASCULAR CONCEPT AND MORE HOT AND CONTROVERSIAL CAROTID TOPICS
Location: Grand Ballroom East, 3rd Floor
Moderators:Mark Conrad, MD, MMSc / Jacob Cynamon, MD, FACR, FSIR / Michael H. Wholey, MD, MBA |
|
x | |
3:30 PM - 3:35 PM | Update On Transvenous Liver Biopsies: What Equipment Is Needed And How To Do Them |
Presenter(s):Jacob Cynamon, MD, FACR, FSIR Location: Grand Ballroom East, 3rd Floor |
|
3:36 PM - 3:41 PM | Floating Clot At The Carotid Bifurcation Is A Prime Indication For Flow Reversal Technology During Treatment Of Carotid Stenosis: How Can Flow Reversal Best Be Achieved In This Setting |
Presenter(s):Juan C. Parodi, MD Location: Grand Ballroom East, 3rd Floor |
|
3:42 PM - 3:47 PM | In Stent Stenosis After CAS: How Can It Be Predicted: When Is It Threatening And How Is It Best Managed |
Presenter(s):Jacques Busquet, MD Location: Grand Ballroom East, 3rd Floor |
|
3:48 PM - 3:53 PM | Anatomic And Procedural Correlates Of Intra- And Postoperative Hypotension With CAS: What Should Be Done About It |
Presenter(s):Michael C. Stoner, MD Location: Grand Ballroom East, 3rd Floor |
|
3:54 PM - 3:59 PM | DEBATE: CAS Is The Best Treatment For Young Healthy Patients With High Grade Asymptomatic Carotid Stenosis (ACS) |
Presenter(s):D. Christopher Metzger, MD Location: Grand Ballroom East, 3rd Floor |
|
4:00 PM - 4:05 PM Power Point Presentation with Synched Audio |
DEBATE:Not So: Even Young Patients With A High Grade ACS Should Not Be Treated By CAS Or CEA: BMT Should Suffice: Are There Any Exceptions |
Presenter(s):Anne L. Abbott, MD, PhD, FRACP Location: Grand Ballroom East, 3rd Floor |
|
4:06 PM - 4:11 PM | Why We Need An RCT Comparing TCAR With TFCAS, Transradial CAS And Best Medical Treatment For ACS And Symptomatic Carotid Stenosis |
Presenter(s):Michael H. Wholey, MD, MBA Location: Grand Ballroom East, 3rd Floor |
|
4:12 PM - 4:17 PM | New Technical Tips To Make Minimal Incision CEA (MICE) Easier And Better: Can Same Day Discharge Be Safe |
Presenter(s):Robert M. Proczka, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
4:18 PM - 4:23 PM | Risks And Causes Of Non-Ipsilateral Stroke Complicating CEA And CAS: How To Decrease Them |
Presenter(s):Mark Conrad, MD, MMSc / W. Darrin Clouse, MD Location: Grand Ballroom East, 3rd Floor |
|
4:24 PM - 4:30 PM | Panel Discussion |
END OF SESSION 85 | |
SESSION 86 SCHEDULE | |
Friday
SESSION 86:
NEW CONCEPTS AND NEW DEVELOPMENTS IN PERCUTANEOUS ACCESS CLOSURE AND WOUND CARE
Location: Grand Ballroom East, 3rd Floor
Moderators:Zvonimir Krajcer, MD, FACC / Mark A. Adelman, MD / Kenneth Ouriel, MD, MBA |
|
x | |
PROGRESS IN PERCUTANEOUS ACCESS AND CLOSURE | |
4:30 PM - 4:35 PM | Update On Large Bore Percutaneous Access Closure: Current Status, New Devices, How To Avoid Complications And Where Do We Go From Here |
Presenter(s):Zvonimir Krajcer, MD, FACC Location: Grand Ballroom East, 3rd Floor |
|
4:36 PM - 4:41 PM | Large Bore Percutaneous Arterial Closure: Which Device Is Best: Advantages And Disadvantages Of The Manta Device |
Presenter(s):Michael J. Singh, MD Location: Grand Ballroom East, 3rd Floor |
|
4:42 PM - 4:47 PM | Current Approaches For Large Bore Device Arterial Closure After Percutaneous EVAR And TEVAR: Technical Tips And Causes Of Failure |
Presenter(s):Gianmarco de Donato, MD Location: Grand Ballroom East, 3rd Floor |
|
4:48 PM - 4:53 PM | How To Use Fascial Suture Technique To Control Percutaneous Large Vessel Access: Technical Tips And When To Use |
Presenter(s):Tal M. Hoerer, MD, PhD / Thomas Larzon, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
4:54 PM - 4:59 PM | Results And Benefits Of The CELT ACD Femoral Arteriotomy Closure Device In The Office-Based Laboratory And Hospital |
Presenter(s):Joseph J. Ricotta II, MD, MS, DFSVS, FACS Location: Grand Ballroom East, 3rd Floor |
|
PROGRESS IN WOUND CARE | |
5:00 PM - 5:05 PM | Update/Review Of Recently Published AHA Guidelines For Treatment Of Diabetic Wounds In The Setting Of PAD |
Presenter(s):Katherine A. Gallagher, MD Location: Grand Ballroom East, 3rd Floor |
|
5:06 PM - 5:11 PM | A Single Device (From AOTI) For Triple Therapy (Local Oxygen, Compression And Humidification) Enhances Healing Of Non-Healing Lower Extremity Wounds And Incisions |
Presenter(s):David J. Dexter, MD Location: Grand Ballroom East, 3rd Floor |
|
5:12 PM - 5:17 PM | New Developments With The TAVITA System To Predict Wound And Amputation Healing And To Monitor The Effectiveness Of Revascularization Procedures: Hyperspectral Imaging Can Non-Invasively Determine Oxygenation And Perfusion: How Does It Work And Results |
Presenter(s):Jan-Willem Elshof, MD Location: Grand Ballroom East, 3rd Floor |
|
5:18 PM - 5:23 PM | Optimal Treatment For Deep Groin Infection After Prosthetic Bypasses From The Common Femoral Artery: How To Save The Graft And The Leg |
Presenter(s):Hosam F. El Sayed, MD Location: Grand Ballroom East, 3rd Floor |
|
5:24 PM - 5:32 PM | Panel Discussion End of Program K |
END OF SESSION 86 | |
SESSION 87 SCHEDULE | |
Friday
SESSION 87:
POPLITEAL DISEASE TOPICS RELATED TO ANEURYSM TREATMENT, ENTRAPMENTS, ADVENTITIAL CYSTIC DISEASE AND TRAUMA
|
|
x | |
POPLITEAL ANEURYSMS AND THEIR BEST CURRENT TREATMENTS | |
6:52 AM - 6:57 AM | Endovascular Repair For Popliteal Artery Aneurysm: Pitfalls And Complications: When Is Open Surgery Best |
Presenter(s):Irwin V. Mohan, MBBS, MD, FRCS, FEBVS, FRACS Location: Grand Ballroom West, 3rd Floor |
|
6:58 AM - 7:03 AM | Treatment Of Popliteal Aneurysms: When Conservative, When Open, When Endovascular: What Are The Hard Data |
Presenter(s):Martin Björck, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
7:04 AM - 7:09 AM | Endovascular Versus Open Repair: Why After 20 Years Of Selective Endografting, I Now Favor Open Repair In Most Patients |
Presenter(s):Martin R. Back, MD Location: Grand Ballroom West, 3rd Floor |
|
7:10 AM - 7:15 AM | Outpatient Endovascular Repair Of Popliteal Artery Aneurysms With Bare Metal Stents: It Shouldn’t Work, But Does: What Is The Evidence |
Presenter(s):Sam S. Ahn, MD, FACS, MBA Location: Grand Ballroom West, 3rd Floor |
|
7:16 AM - 7:21 AM | Rescue Procedures For Failed Endovascular Repairs Of Popliteal Aneurysms: Observation May Be Enough: If Not, Hybrid Versus Open Repair: Technical Tips |
Presenter(s):Jose Fernandes e Fernandes, MD, PhD, FRCS (Eng), FACS, FESC, FEBVS Location: Grand Ballroom West, 3rd Floor |
|
ENTRAPMENTS, ADVENTITIAL CYSTIC DISEASE AND TRAUMA | |
7:22 AM - 7:29 AM | Updates On The Diagnosis And Treatment Of Popliteal Entrapments: What Are Their Misleading (Doppelganger) Diagnoses |
Presenter(s):Katherine A. Gallagher, MD Location: Grand Ballroom West, 3rd Floor |
|
7:30 AM - 7:35 AM | Management Of Functional Popliteal Artery Entrapment Syndrome In Athletes: What Is The Pathological Anatomy And What Symptoms Does It Cause: Technique Of Surgical Repair |
Presenter(s):Jason T. Lee, MD Location: Grand Ballroom West, 3rd Floor |
|
7:36 AM - 7:41 AM | Adventitial Cystic Disease Of The Popliteal Artery: Pathogenesis, Symptoms And Optimal Treatment |
Presenter(s):Irwin V. Mohan, MBBS, MD, FRCS, FEBVS, FRACS Location: Grand Ballroom West, 3rd Floor |
|
7:42 AM - 7:47 AM | What Is The Surgical Approach And Best Graft Usage For Popliteal Artery Injury From Posterior Knee Dislocation: How Can Associated Vein Injury Be Detected And What Should Its Treatment Be |
Presenter(s):Charles J. Fox, MD, FACS Location: Grand Ballroom West, 3rd Floor |
|
7:48 AM - 7:56 AM | Panel Discussion |
END OF SESSION 87 | |
SESSION 88 SCHEDULE | |
Friday
SESSION 88:
NEW DEVELOPMENTS IN TREATING ARTERIAL (INCLUDING AORTIC) GRAFT INFECTIONS
|
|
x | |
7:56 AM - 8:01 AM | Update On The NAIS Procedure (Deep Vein Reconstruction) For Infected Aortic Grafts: How To Make The Operation Easier And Faster: When Is It Indicated |
Presenter(s):John F. Eidt, MD Location: Grand Ballroom West, 3rd Floor |
|
TREATMENT OF MYCOTIC ANEURYSMS | |
8:02 AM - 8:07 AM | What Is The Best Treatment For Mycotic Aneurysms: Open, Endo, Or Hybrid: When Is EVAR Helpful |
Presenter(s):Yamume Tshomba, MD Location: Grand Ballroom West, 3rd Floor |
|
8:08 AM - 8:13 AM | Rifampin Soaked Endografts To Treat Mycotic AAAs: How To Prepare Them And When To Use Them: Are They Stand-Alone Treatment Or Do They Need Adjunctive Techniques |
Presenter(s):Guillermo A. Escobar, MD Location: Grand Ballroom West, 3rd Floor |
|
TREATMENT OF AORTIC AND ARTERIAL GRAFT AND ENDOGRAFT INFECTIONS | |
8:14 AM - 8:19 AM | For Many Infected Prosthetic Arterial/Aortic Grafts, Endografts And Mycotic Aneurysms Less Than The Current Standard Radical Graft Excisional Treatment Is Best: Details And Examples Of This Less Radical Treatment |
Presenter(s):Martin Malina, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
8:20 AM - 8:25 AM | Support For The Graft Preservation Concept For Treating Prosthetic Aortic Graft Infections From A European Multicenter Study (VASGRA): All Or Part Of The Infected Graft May Be Preserved: Under What Circumstances |
Presenter(s):Zoran Rancic, MD, PhD, EMBA HSG Location: Grand Ballroom West, 3rd Floor |
|
8:26 AM - 8:31 AM | Optimal Techniques In 2024 For Treating Infected Aortoiliac Prosthetic Grafts And Endografts (Including EVAR, TEVAR, F/B/EVAR): From A Large National Cohort And The GRANDPA Global Registry |
Presenter(s):Anders Wanhainen, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
8:32 AM - 8:37 AM | Panel Discussion |
8:38 AM - 8:43 AM | With Aortic Graft Infection, How Can Inline (In Situ) Flow Be Reestablished: Indications: What Grafts: Technical Tips: Results |
Presenter(s):Peter F. Lawrence, MD Location: Grand Ballroom West, 3rd Floor |
|
8:44 AM - 8:49 AM | Infected Endografts After EVAR: Etiological Factors, Diagnosis, Treatment: Does The Endograft Always Have To Be Removed |
Presenter(s):Mohammad H. Eslami, MD, MPH Location: Grand Ballroom West, 3rd Floor |
|
8:50 AM - 8:55 AM | The Real Truth About Use Of Cryopreserved Conduits (CryoGraft-Artivion) To Treat Infected Aortic/Arterial Reconstructions: From A Large Single Center Experience: There Are Advantages And Limitations |
Presenter(s):Randall R. De Martino, MD / Manju Kalra, MBBS Location: Grand Ballroom West, 3rd Floor |
|
8:56 AM - 9:01 AM | Update On Surgical Treatment For Infected Thoracic Aortic Grafts And Endografts, With Or Without Aorto-Esophageal Or Aorto-Bronchial Fistulas: Optimal Techniques And Results From A Committed Center |
Presenter(s):Germano C.G. Melissano, MD / Andrea Kahlberg, MD / Roberto L.V. Chiesa, MD Location: Grand Ballroom West, 3rd Floor |
|
9:02 AM - 9:07 AM | TEVAR For The Treatment Of Aorto-Esophageal And Aorto-Bronchial Fistulas: Is It Only A Bridging Procedure Or Is It Ever A Definitive Treatment |
Presenter(s):Markus K. Furrer, MD Location: Grand Ballroom West, 3rd Floor |
|
9:08 AM - 9:13 AM | Treatment Of Infected Aortic Grafts (Endo And Open): Explantation Or Preservation: Technical Tips |
Presenter(s):Javairiah Fatima, MD Location: Grand Ballroom West, 3rd Floor |
|
9:14 AM - 9:20 AM | Panel Discussion |
9:20 AM - 9:34 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 88 | |
SESSION 89 SCHEDULE | |
Friday
SESSION 89:
PROGRESS IN VASCULAR IMAGING AND GUIDANCE FOR ENDOVASCULAR TREATMENTS WITH LESS RADIATION EXPOSURE OR CONTRAST TOXICITY
Location: Grand Ballroom West, 3rd Floor
Moderators:Matthew J. Eagleton, MD / Jan M.M. Heyligers, MD, PhD, FEBVS |
|
x | |
9:34 AM - 9:39 AM | Advantages And Disadvantages Of The Three Main Hybrid OR Suites (GE, Siemens, Philips): How To Pick The Best One For Your Institution |
Presenter(s):Bjoern D. Suckow, MD Location: Grand Ballroom West, 3rd Floor |
|
ADVANCED ENDOVASCULAR GUIDANCE WITH LESS RADIATION | |
9:40 AM - 9:45 AM | 3-Dimensional Advanced Guidance Systems For Endovascular Procedures: How Do The IOPS (Centerline), FORS (Philips), And Cydar (Medtronic) Systems Work And Reduce The Need For Radiation |
Presenter(s):Mark A. Adelman, MD Location: Grand Ballroom West, 3rd Floor |
|
9:46 AM - 9:51 AM | With F/B/EVAR For Complex AAAs, FORS Lumiguide Fiberoptic Guidance (Philips) Reduces Radiation Exposure Compared To Standard Imaging |
Presenter(s):Marc L. Schermerhorn, MD Location: Grand Ballroom West, 3rd Floor |
|
9:52 AM - 9:57 AM | New Developments With The IOPS (Centerline) Guidance System For F/B/EVAR: How Effective Is It Proving To Be: Advantages And Limitations |
Presenter(s):Matthew J. Eagleton, MD Location: Grand Ballroom West, 3rd Floor |
|
9:58 AM - 10:03 AM | What Is Redo Fusion And How Does It Help After Failed Endovascular Complex Aortic Procedures |
Presenter(s):Giovanni Tinelli, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
10:04 AM - 10:09 AM | Panel Discussion |
DUPLEX AND INTRAVASCULAR ULTRASOUND | |
10:10 AM - 10:15 AM | Duplex Ultrasound Guidance: When Can It Replace Fluoroscopy For Endovascular Procedures: Requirements, Advantages, Limitations: Is Its Use Becoming Widespread |
Presenter(s):Enrico Ascher, MD / Natalie A. Marks, MD, RPVI, RVT, FSVM Location: Grand Ballroom West, 3rd Floor |
|
10:16 AM - 10:21 AM | Intraprocedural Duplex Ultrasound Guidance May Be Better And Cheaper Than IVUS For Most Endovascular Cases: When Is It Not |
Presenter(s):Eric A. Secemsky, MD, MSc Location: Grand Ballroom West, 3rd Floor |
|
EKG-GATED CTA | |
10:22 AM - 10:27 AM | EKG-Gated CTA And Its Added Value For Sizing EVAR And TEVAR Endografts: How It Decrease Failures |
Presenter(s):Frans L. Moll, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
VASCULAR HOLOGRAPHY | |
10:28 AM - 10:33 AM | Update On The ARCUS System Of Augmented Reality (Derived From A Contrast CT) And Its Value In Vascular And Endovascular Procedures: How Does It Work And Experience To Date |
Presenter(s):Jan M.M. Heyligers, MD, PhD, FEBVS Location: Grand Ballroom West, 3rd Floor |
|
10:34 AM - 10:39 AM | Update On Holographic Guidance Of Endovascular Procedures (With Augmented Reality Goggles And No Screen): How Does It Work And Clinical Experience: What Is Possible And What Is Not |
Presenter(s):Claude Mialhe, MD Location: Grand Ballroom West, 3rd Floor |
|
10:40 AM - 10:48 AM | Panel Discussion |
END OF SESSION 89 | |
SESSION 90 SCHEDULE | |
Friday
SESSION 90:
AUGMENTED REALITY (AR), MIXED REALITY AND ARTIFICIAL INTELLIGENCE (AI): HOW WILL THEY IMPROVE VASCULAR IMAGING AND ENDOVASCULAR DEVICE GUIDANCE WHILE MINIMIZING RADIATION
Location: Grand Ballroom West, 3rd Floor
Moderators:Gustavo S. Oderich, MD, FACS / Alan B. Lumsden, MD, FACS / Kak Khee Yeung, MD, PhD |
|
x | |
10:49 AM - 12:00 PM | PROGRAM TO BE DETERMINED |
12:00 PM - 1:00 PM | Lunch Break – Rhinelander Gallery, 2nd Floor Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 90 | |
SESSION 91 SCHEDULE | |
Friday
SESSION 91:
PRESENTATIONS AND CHALLENGING RECORDED LIVE CASES FROM MÜNSTER, GERMANY
|
|
x | |
1:00 PM - 1:37 PM | PROGRAM TO BE DETERMINED |
END OF SESSION 91 | |
SESSION 92 SCHEDULE | |
Friday
SESSION 92:
NEW DEVELOPMENTS IN THE TREATMENT OF THORACIC OUTLET SYNDROMES (TOSs)
|
|
x | |
1:38 PM - 1:43 PM | For Venous TOS An Anterior Infraclavicular Approach Permits Resection Of The Anterior Third Of The First Rib Which Is Sufficient: Technique, Limitations And Results |
Presenter(s):Keith D. Calligaro, MD / Matthew J. Dougherty, MD Location: Grand Ballroom West, 3rd Floor |
|
1:44 PM - 1:49 PM | Minimal Invasive Transaxillary First Rib Resection Under Local And Regional Anesthesia For TOSs: How To Do It, Limitations And Precautions |
Presenter(s):Francesco Spinelli, MD Location: Grand Ballroom West, 3rd Floor |
|
1:50 PM - 1:55 PM | To Treat Various Forms Of TOSs Resection Of The Middle Third Of The First Rib Is Sufficient: A 30-Year Experience: How To Do It And When Not To |
Presenter(s):Claude D. Vaislic, MD Location: Grand Ballroom West, 3rd Floor |
|
1:56 PM - 2:01 PM | Robotic Approach To Thoracic Outlet Decompression: How To Do It: Limitations And Contraindications |
Presenter(s):Katherine A. Teter, MD Location: Grand Ballroom West, 3rd Floor |
|
2:02 PM - 2:07 PM | Supraclavicular Approach To Arterial And Neurogenic TOSs (Video Presentation) |
Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS Location: Grand Ballroom West, 3rd Floor |
|
2:08 PM - 2:13 PM | Botox Injections In The Treatment Of Neurogenic TOS: How Does It Work, When To Do It, How To Do It And Results |
Presenter(s):Jason T. Lee, MD Location: Grand Ballroom West, 3rd Floor |
|
2:14 PM - 2:19 PM | Adolescent Neurogenic And Vascular TOSs: They Are Different And Uniquely Challenging: How To Diagnose Them And How Best To Treat Them In Athletes And Non-Athletes |
Presenter(s):Michael J. Singh, MD Location: Grand Ballroom West, 3rd Floor |
|
2:20 PM - 2:25 PM | Subclavian Artery Aneurysms In Patients With Genetic Arteriopathy: How Should They Be Worked Up And Treated |
Presenter(s):Sherene Shalhub, MD, MPH Location: Grand Ballroom West, 3rd Floor |
|
2:26 PM - 2:32 PM | Panel Discussion |
2:32 PM - 2:42 PM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 92 | |
SESSION 93 SCHEDULE | |
Friday
SESSION 93:
BEST ANTIPLATELET REGIMENS UPDATE ON RARE VASCULAR DISEASES; NEW DEVELOPMENTS IN ANTIPLATELET AND ANTICOAGULATION REGIMENS AND MEDICAL AND DRUG TREATMENTS
|
|
x | |
UPDATE ON TREATMENT OF RARE VASCULAR DISEASES | |
2:42 PM - 2:47 PM | Optimal Current Management Of Takayasu's Disease Involving The Supra-Aortic Branches: Technical Details For Open Surgical Management And What Is The Role For Endo Treatment With Bare Or Covered Stents |
Presenter(s):Kellie R. Brown, MD Location: Grand Ballroom West, 3rd Floor |
|
2:48 PM - 2:53 PM | The Present Status Of Buerger’s Disease: Does It Still Exist; How To Diagnose And Treat It |
Presenter(s):Kamphol Laohapensang, MD Location: Grand Ballroom West, 3rd Floor |
|
2:54 PM - 2:59 PM | How To Make Operations For Complications Of Vascular Ehlers Danlos Syndrome Go Well |
Presenter(s):James H... Black, III, MD Location: Grand Ballroom West, 3rd Floor |
|
3:00 PM - 3:05 PM Power Point Presentation with Synched Audio |
Medical Treatment Of Patients With Vascular Ehlers Danlos Syndrome: How Does Celiprolol Treatment Work And How Does It Help |
Presenter(s):Martin Björck, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
ANTIPLATELET AND ANTICOAGULATION TREATMENT | |
3:06 PM - 3:11 PM | Current Optimal Antiplatelet And Anticoagulation Treatment For Various Vascular Procedures In Various Vascular Beds: What Newer Drugs And DOACs Are Useful And What Is The Optimal Timing Of Treatment |
Presenter(s):Peter Henke, MD Location: Grand Ballroom West, 3rd Floor |
|
3:12 PM - 3:17 PM | Understanding The Barriers To Antiplatelet And Statin Adherence Following Vascular Interventions: What Should Be Done About It |
Presenter(s):Wei Zhou, MD Location: Grand Ballroom West, 3rd Floor |
|
3:18 PM - 3:23 PM | Panel Discussion |
3:24 PM - 3:29 PM | Next Generation Antithrombotic Agents: What’s On The Horizon For Anticoagulant And Antithrombotic Drugs: How Will They Work And How Helpful Will They Be |
Presenter(s):Elliot L. Chaikof, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
3:30 PM - 3:35 PM | Lowering LDL-C And Controlling Elevated Blood Pressure And Lipoprotein Little A [Lp(a)] Can Lower Cardiovascular Risk 80%: What To Do If Patients Can’t Tolerate A Statin Dose: Ezetimibe (Zetia), A PCSK9 Inhibitor, Inclisiran, Bempedoic Acid (Nexletol), Etc. |
Presenter(s):Richard Bulbulia, MA, MD, FRCS |
|
NEW DEVELOPMENTS IN MEDICAL MANAGEMENT | |
3:36 PM - 3:41 PM | What Are The Best Medical Treatments After Carotid, Aortic And Lower Extremity Endovascular And Open Procedures |
Presenter(s):Maciej L. Dryjski, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
3:42 PM - 3:47 PM | Value And Limitations Of Statins And Non-Statin Lipid Lowering Agents And Other Medical Treatments In Patients With Carotid Artery Stenosis: Should They Be The Same Or Different In Patients Undergoing Invasive Procedures |
Presenter(s):Kosmas I. Paraskevas, MD Location: Grand Ballroom West, 3rd Floor |
|
3:48 PM - 3:52 PM | Panel Discussion |
END OF SESSION 93 | |
SESSION 94 SCHEDULE | |
Friday
SESSION 94:
ADVANCES IN THE ENDO AND OPEN TREATMENT OF VASCULAR TRAUMA
Location: Grand Ballroom West, 3rd Floor
Moderators:Todd E. Rasmussen, MD, FACS / Gilbert R. Upchurch, MD |
|
x | |
3:52 PM - 3:57 PM | Vascular Injuries After Blunt Abdominal Trauma: Diagnosis And Management: When Endo, When Open Treatment |
Presenter(s):Dittmar Boeckler, MD Location: Grand Ballroom West, 3rd Floor |
|
3:58 PM - 4:03 PM | New Developments In The Endovascular Management Of Vascular Injuries: How Can A Hybrid Suite Be Helpful |
Presenter(s):Ravi R. Rajani, MD Location: Grand Ballroom West, 3rd Floor |
|
UPDATE ON BLUNT THORACIC AORTIC INJURY (BTAI) | |
4:04 PM - 4:09 PM | How To Manage Heparin In TEVAR For BTAI When Head Or Other Injuries Are Also Present: Some, None Or Just Sheath Flushing |
Presenter(s):Charles J. Fox, MD, FACS Location: Grand Ballroom West, 3rd Floor |
|
4:10 PM - 4:15 PM | Outcomes Of BTAI In >1,000 Patients: When Is Observation The Best Treatment; When Is TEVAR Best: When Is It Not: Technical Tips: From The Aortic Trauma Foundation Registry |
Presenter(s):Ali Azizzadeh, MD Location: Grand Ballroom West, 3rd Floor |
|
4:16 PM - 4:21 PM | Acute Thoracic Aortic Pseudo-Coarctation After BTAI: What Is It: How Does It Produce Distal Organ Ischemia: How Should It Be Diagnosed And Treated Emergently By TEVAR: Technical Tips |
Presenter(s):Erica L. Mitchell, MD, MEd Location: Grand Ballroom West, 3rd Floor |
|
4:22 PM - 4:27 PM | Classification Of BTAIs In Adults And Pediatric Patients: The Evidence Shows That Grade I And II Lesions Can Be Treated Conservatively Whereas Grades III And IV Should Be Treated Endovascularly: Recommendations For Graft Sizing In Children |
Presenter(s):Elina Quiroga, MD, MPH Location: Grand Ballroom West, 3rd Floor |
|
4:28 PM - 4:33 PM | Update On The Retrievable Rescue Stent-Graft For Treating Aortic And Vena Cava Injuries: What Is It: How Does It Work And Current Status |
Presenter(s):Bryan W. Tillman, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
4:34 PM - 4:39 PM | Update On Resuscitative Endovascular Balloon Occlusion Of The Aorta (REBOA): When Is It A Valuable Procedure And When Is It Not: Limitations And Precautions |
Presenter(s):Gilbert R. Upchurch, MD Location: Grand Ballroom West, 3rd Floor |
|
4:40 PM - 4:45 PM | Evolving Techniques In Pediatric Vascular And Endovascular Trauma Surgery: What Special Precautions Are Needed: How To Deal With Arterial Spasm: When And How Can Endovascular Grafts Be Used |
Presenter(s):Michael C. Dalsing, MD Location: Grand Ballroom West, 3rd Floor |
|
4:46 PM - 4:56 PM | Panel Discussion End of Program L |
END OF SESSION 94 | |
SESSION 95 SCHEDULE | |
Friday
SESSION 95:
DEEP VENOUS PHYSIOLOGY AND VENOUS STENT ISSUES
Location: Trianon Ballroom, 3rd Floor
Moderators:Jose I. Almeida, MD, FACS, RPVI, RVT / Lowell S. Kabnick, MD, FACS, FAVLS, DFAVF |
|
x | |
7:30 AM - 7:34 AM | Introduction: Deep System |
Presenter(s):Lowell S. Kabnick, MD, FACS, FAVLS, DFAVF Location: Trianon Ballroom, 3rd Floor |
|
7:35 AM - 7:40 AM | Why Do We Call It Venous Hypertension |
Presenter(s):Brajesh K. Lal, MD Location: Trianon Ballroom, 3rd Floor |
|
7:41 AM - 7:46 AM | Appropriate Patient Selection For Iliac Vein Stenting |
Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT Location: Trianon Ballroom, 3rd Floor |
|
7:47 AM - 7:52 AM | Is 50% Stenosis The Cutpoint For Stenting |
Presenter(s):Mark H. Meissner, MD Location: Trianon Ballroom, 3rd Floor |
|
7:53 AM - 7:58 AM | Iliocaval Duplex Ultrasound With Image Optimization |
Presenter(s):Jan M. Sloves, RVT Location: Trianon Ballroom, 3rd Floor |
|
7:59 AM - 8:04 AM | Physiologic Assessment Of The Severity Of Iliac Vein Obstruction |
Presenter(s):Fedor Lurie, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
8:05 AM - 8:10 AM | Approaching The NIVL Patient: How To Ensure Success |
Presenter(s):Mahmood Razavi, MD Location: Trianon Ballroom, 3rd Floor |
|
8:11 AM - 8:16 AM | An Ultrasound Imaging And Computational Fluid Dynamic Protocol To Assess Hemodynamics In Iliac Vein Compression Syndrome |
Presenter(s):C. Alberto Figueroa, PhD Location: Trianon Ballroom, 3rd Floor |
|
8:17 AM - 8:22 AM | Panel Discussion |
END OF SESSION 95 | |
SESSION 96 SCHEDULE | |
Friday
SESSION 96:
VENOUS STENT TRIALS
Location: Trianon Ballroom, 3rd Floor
Moderators:Alun H. Davies, MA, DM, DSc, FRCS, FLSW, FMedSci, FEBVS / Stephen A. Black, MD |
|
x | |
8:23 AM - 8:28 AM | RCT: Venous Stenting Versus Conservative Treatment In Deep Venous Obstruction |
Presenter(s):Houman Jalaie, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
8:29 AM - 8:34 AM | Early Experience With The Gore Viafort Venous Stent |
Presenter(s):Andrew Holden, MBChB Location: Trianon Ballroom, 3rd Floor |
|
8:35 AM - 8:40 AM | The BEYOND Venous Stent Registry |
Presenter(s):Michael K.W. Lichtenberg, MD Location: Trianon Ballroom, 3rd Floor |
|
8:41 AM - 8:46 AM | Criteria To Predict Mid-Term Outcome After Stenting Of Chronic Iliac Vein Obstructions (PROMISE Trial) |
Presenter(s):Iris Baumgartner, MD Location: Trianon Ballroom, 3rd Floor |
|
8:47 AM - 8:52 AM | Will The BEST Trial Answer The Question On Iliac Stenting |
Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FLSW, FMedSci, FEBVS Location: Trianon Ballroom, 3rd Floor |
|
8:53 AM - 8:58 AM | A Look At Long-Term Venous Stent Data: ABRE Study 36-Month Clinical Outcome |
Presenter(s):Stephen A. Black, MD Location: Trianon Ballroom, 3rd Floor |
|
8:59 AM - 9:04 AM | Zilver Vena Stent Trial: 4-Year Outcomes |
Presenter(s):Anthony J. Comerota, MD, FACS, FACC Location: Trianon Ballroom, 3rd Floor |
|
9:05 AM - 9:10 AM | Venovo Venous Registry: 36-Month Data Report From A Real World Registry |
Presenter(s):Michael K.W. Lichtenberg, MD Location: Trianon Ballroom, 3rd Floor |
|
9:11 AM - 9:16 AM | Panel Discussion |
END OF SESSION 96 | |
SESSION 97 SCHEDULE | |
Friday
SESSION 97:
FEMORO-ILIOCAVAL CHRONIC TOTAL OCCLUSIONS, RECANALIZATION TECHNIQUES AND OTHER CONSIDERATIONS
Location: Trianon Ballroom, 3rd Floor
Moderators:Jose I. Almeida, MD, FACS, RPVI, RVT / Lowell S. Kabnick, MD, FACS, FAVLS, DFAVF |
|
x | |
9:17 AM - 9:22 AM | Steps To Minimize Complications During Central Venous Recanalization |
Presenter(s):Marcelo Guimaraes, MD, MBA, FSIR Location: Trianon Ballroom, 3rd Floor |
|
9:23 AM - 9:28 AM | Ruptured IVC And Iliac Vein: Now What |
Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT Location: Trianon Ballroom, 3rd Floor |
|
9:29 AM - 9:34 AM | Outcomes And Predictors Of Failure Of Iliac Vein Stenting |
Presenter(s):Rabih A. Chaer, MD Location: Trianon Ballroom, 3rd Floor |
|
9:35 AM - 9:40 AM | Preclinical Data On Sirolimus Coated Balloons In Deep Veins: Results From The vSTRIDE Trial |
Presenter(s):Andrea T. Obi, MD Location: Trianon Ballroom, 3rd Floor |
|
9:41 AM - 9:46 AM | Results Of Revcore For Use In Chronic Deep Vein Stent Occlusion |
Presenter(s):Steven D. Abramowitz, MD Location: Trianon Ballroom, 3rd Floor |
|
9:47 AM - 9:52 AM | Hybrid Open And Endovascular Techniques For Complex Iliofemoral Disease |
Presenter(s):Erin H. Murphy, MD Location: Trianon Ballroom, 3rd Floor |
|
9:53 AM - 9:58 AM | Endovascular Brachiocephalic And IVC Bypass Graft Creation: Changing What Is (Im)Possible |
Presenter(s):Marcelo Guimaraes, MD, MBA, FSIR Location: Trianon Ballroom, 3rd Floor |
|
9:59 AM - 10:04 AM | Veins Aren’t Round – Stented Veins Don’t Need To Be Either |
Presenter(s):Lowell S. Kabnick, MD, FACS, FAVLS, DFAVF Location: Trianon Ballroom, 3rd Floor |
|
10:05 AM - 10:10 AM | Panel Discussion |
END OF SESSION 97 | |
SESSION 98 SCHEDULE | |
Friday
SESSION 98:
VENOUS THROMBOSIS SCIENCE AND TREATMENT STRATEGIES
|
|
x | |
10:11 AM - 10:16 AM | Have Venous Trials Changed The Management Of The Ilio-Femoral DVT In 2024 |
Presenter(s):Ali Amin, MD, RVT, FACS, FACC Location: Trianon Ballroom, 3rd Floor |
|
10:17 AM - 10:22 AM | Update Of Post-Thrombotic Syndrome Prevention |
Presenter(s):Tomasz Urbanek, MD Location: Trianon Ballroom, 3rd Floor |
|
10:23 AM - 10:28 AM | Update On Experimental DVT Vein Wall Injury |
Presenter(s):Peter Henke, MD Location: Trianon Ballroom, 3rd Floor |
|
10:29 AM - 10:34 AM | Venous Thromboembolism In The Context Of Chronic Venous Disease |
Presenter(s):Thomas W. Wakefield, MD Location: Trianon Ballroom, 3rd Floor |
|
10:35 AM - 10:40 AM | Inflow Assessment In PTS Patients |
Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT Location: Trianon Ballroom, 3rd Floor |
|
10:41 AM - 10:46 AM | Why Do VTE Risk Scores Fail To Prevent VTE |
Presenter(s):Peter Henke, MD Location: Trianon Ballroom, 3rd Floor |
|
10:47 AM - 10:52 AM | Inflammation, Selectins And Venous Thrombosis |
Presenter(s):Thomas W. Wakefield, MD Location: Trianon Ballroom, 3rd Floor |
|
10:53 AM - 10:58 AM | Predictive Modeling For Post-Thrombotic Syndrome In DVT Patients |
Presenter(s):Steven D. Abramowitz, MD Location: Trianon Ballroom, 3rd Floor |
|
10:59 AM - 11:04 AM | Assessing Radiation Exposure To Patients During Recanalization Of Chronic Venous Obstruction |
Presenter(s):Houman Jalaie, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
11:05 AM - 11:10 AM | Panel Discussion |
END OF SESSION 98 | |
SESSION 99 SCHEDULE | |
Friday
SESSION 99:
THROMBUS REMOVAL THROMBECTOMY DEVICES AND OTHER ISSUES TO CONSIDER
|
|
x | |
11:11 AM - 11:16 AM | P-Max Study: Mechanical Thrombectomy For Iliofemoral DVT With Aspirex – 24-Month Results |
Presenter(s):Michael K.W. Lichtenberg, MD Location: Trianon Ballroom, 3rd Floor |
|
11:17 AM - 11:22 AM | Tips And Tricks With Lightning FLASH For PE And DVT Patients |
Presenter(s):Patrick E. Muck, MD, FACS Location: Trianon Ballroom, 3rd Floor |
|
11:23 AM - 11:28 AM | New Percutaneous Thrombectomy Reperfusion System |
Presenter(s):Patrick E. Muck, MD, FACS Location: Trianon Ballroom, 3rd Floor |
|
11:29 AM - 11:34 AM | CLOUT Registry For The Inari CloTriever |
Presenter(s):David J. Dexter, MD Location: Trianon Ballroom, 3rd Floor |
|
11:35 AM - 11:40 AM | Management Of IVC Thrombus Using Large Bore Mechanical Thrombectomy |
Presenter(s):Constantino Pena, MD Location: Trianon Ballroom, 3rd Floor |
|
11:41 AM - 11:46 AM | Panel Discussion |
END OF SESSION 99 | |
SESSION 100 SCHEDULE | |
Friday
SESSION 100:
VENOUS REFLUX ISSUES AND DEEP VEIN VALVE TECHNOLOGIES
|
|
x | |
11:47 AM - 11:52 AM | Obstruction Or Reflux: What To Treat First In Venous Ulcers |
Presenter(s):Robert B. McLafferty, MD, MBA Location: Trianon Ballroom, 3rd Floor |
|
11:53 AM - 11:58 AM | When Deep Venous Reflux Repair Is Not Effective: What Next |
Presenter(s):Marzia Lugli, MD Location: Trianon Ballroom, 3rd Floor |
|
11:59 AM - 12:04 PM | Deep Venous Reflux In Patients Undergoing Venous Treatments |
Presenter(s):Mikel Sadek, MD Location: Trianon Ballroom, 3rd Floor |
|
12:05 PM - 12:10 PM | Deep Reflux: What Happens After Concomitant Obstruction Correction |
Presenter(s):Marzia Lugli, MD Location: Trianon Ballroom, 3rd Floor |
|
12:11 PM - 12:16 PM | Deep Vein Valve Devices: What Outcome Measures Should Be Used |
Presenter(s):Fedor Lurie, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
12:17 PM - 12:22 PM | Long-Term Results Of The SAVVE Trial: A Bioprosthetic Valve |
Presenter(s):David J. Dexter, MD Location: Trianon Ballroom, 3rd Floor |
|
12:23 PM - 12:28 PM | Endovenous Delivery Of New Valve Prosthesis In Humans: The New Trend |
Presenter(s):Jorge H. Ulloa, MD, FACS Location: Trianon Ballroom, 3rd Floor |
|
12:29 PM - 12:34 PM | An Update On The Cook Venous Valve Project |
Presenter(s):Paul J. Gagne, MD Location: Trianon Ballroom, 3rd Floor |
|
12:35 PM - 12:40 PM | Ambulatory Venous Pressure Measurement Via Column Interruption Duration |
Presenter(s):Seshadri Raju, MD Location: Trianon Ballroom, 3rd Floor |
|
12:41 PM - 12:45 PM | Panel Discussion |
12:45 PM - 1:03 PM | Lunch Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 100 | |
SESSION 101 SCHEDULE | |
Friday
SESSION 101:
PELVIC VEIN DISORDERS
|
|
x | |
1:04 PM - 1:09 PM | The Role Of Conservative Pelvic Vein Management |
Presenter(s):Mark H. Meissner, MD Location: Trianon Ballroom, 3rd Floor |
|
1:10 PM - 1:15 PM | Management Of Symptomatic Vulvar Varices With And Without Pelvic Symptoms |
Presenter(s):Steve Elias, MD Location: Trianon Ballroom, 3rd Floor |
|
1:16 PM - 1:21 PM | Pelvic Venous Disease: New Terminology, New Treatment Approach, Still No Level 1 Data |
Presenter(s):Lindsay Machan, MD Location: Trianon Ballroom, 3rd Floor |
|
1:22 PM - 1:27 PM | Ovarian Vein Embolization: Which Patients Benefit |
Presenter(s):Constantino Pena, MD Location: Trianon Ballroom, 3rd Floor |
|
1:28 PM - 1:33 PM | Treatment Algorithm For Left Renal Vein Compression |
Presenter(s):Cynthia K. Shortell, MD Location: Trianon Ballroom, 3rd Floor |
|
1:34 PM - 1:39 PM | Outcomes Of Left Renal Vein Stenting In Patients With Nutcracker Syndrome |
Presenter(s):Rabih A. Chaer, MD Location: Trianon Ballroom, 3rd Floor |
|
1:40 PM - 1:45 PM | Open Surgical And Endovascular Treatment Of Nutcracker Syndrome: Do We Have The Answer Now |
Presenter(s):Manju Kalra, MBBS Location: Trianon Ballroom, 3rd Floor |
|
1:46 PM - 1:51 PM | RCT Of Pelvic Venous Embolization Versus Sham Procedure For Venous Origin Chronic Pelvic Pain In Women |
Presenter(s):Neil M. Khilnani, MD Location: Trianon Ballroom, 3rd Floor |
|
1:52 PM - 1:57 PM | Management Of Combined Iliac Vein Obstruction And Ovarian Reflux |
Presenter(s):Kush R. Desai, MD Location: Trianon Ballroom, 3rd Floor |
|
1:58 PM - 2:03 PM | Panel Discussion |
END OF SESSION 101 | |
SESSION 102 SCHEDULE | |
Friday
SESSION 102:
MORE VENOUS THROMBOSIS
|
|
x | |
2:04 PM - 2:09 PM | Anticoagulation In Childhood, The Role For DOACs |
Presenter(s):Dawn M. Coleman, MD, FACS Location: Trianon Ballroom, 3rd Floor |
|
2:10 PM - 2:15 PM | Management Of Venous Thoracic Outlet Syndrome |
Presenter(s):Chandu Vemuri, MD Location: Trianon Ballroom, 3rd Floor |
|
2:16 PM - 2:21 PM | Which DOAC For What Disease: Review Of Ongoing Trials |
Presenter(s):Andrea T. Obi, MD Location: Trianon Ballroom, 3rd Floor |
|
2:22 PM - 2:27 PM | Hypercoagulable Work Up, Thrombophilia Testing, And Duration Of Anticoagulation |
Presenter(s):Rachel Rosovsky, MD, MPH Location: Trianon Ballroom, 3rd Floor |
|
2:28 PM - 2:33 PM | SVT Treatment Options: DOAC, LMWH, Nothing |
Presenter(s):Steve Elias, MD Location: Trianon Ballroom, 3rd Floor |
|
2:34 PM - 2:39 PM | Update On Reversal Agents For The DOACs |
Presenter(s):Timothy K. Liem, MD, MBA Location: Trianon Ballroom, 3rd Floor |
|
2:40 PM - 2:45 PM | Factor XI Inhibitors: What Are They |
Presenter(s):Alex C. Spyropoulos, MD |
|
2:46 PM - 2:51 PM | Panel Discussion |
END OF SESSION 102 | |
SESSION 103 SCHEDULE | |
Friday
SESSION 103:
IVC FILTERS AND MORE ISSUES WITH STENTS
|
|
x | |
2:52 PM - 2:57 PM | IVC Filter Retrieval: Basic And Advanced |
Presenter(s):Ripal T. Gandhi, MD, FSVM, FSIR Location: Trianon Ballroom, 3rd Floor |
|
2:58 PM - 3:03 PM | Bertram D. Cohn's Contributions To The Development Of The Original IVC Filter |
Presenter(s):Enrico Ascher, MD Location: Trianon Ballroom, 3rd Floor |
|
3:04 PM - 3:09 PM | What To Do With Fractured Filters And Embolic Filter Fragments |
Presenter(s):Constantino Pena, MD Location: Trianon Ballroom, 3rd Floor |
|
3:10 PM - 3:15 PM | Laser-Assisted IVC Filter Retrieval: When And How |
Presenter(s):Kush R. Desai, MD |
|
3:16 PM - 3:21 PM | Denali Filter Experience |
Presenter(s):Eric Hager, MD Location: Trianon Ballroom, 3rd Floor |
|
3:22 PM - 3:27 PM | Surgical Removal Of IVC Filters: Perforation Or Infiltration |
Presenter(s):Timothy K. Liem, MD, MBA |
|
3:28 PM - 3:33 PM | Rethinking Filters: The Latest Evidence From The Cook IVC Filter Study |
Presenter(s):Rabih A. Chaer, MD Location: Trianon Ballroom, 3rd Floor |
|
3:34 PM - 3:39 PM | Migration Of Iliac And Renal Vein Stents: T-Stent Might Be A Solution To The Problem |
Presenter(s):Peter Gloviczki, MD Location: Trianon Ballroom, 3rd Floor |
|
3:40 PM - 3:45 PM | Outcome Of Venous Stents In Adolescents, Teenagers, And Pregnancy |
Presenter(s):Mahmood Razavi, MD Location: Trianon Ballroom, 3rd Floor |
|
3:46 PM - 3:51 PM | Acute Iliofemoral DVT In Adolescents And Young Adults And Whether They Should Undergo Stenting For May Thurner At The Time Of DVT Intervention |
Presenter(s):William A. Marston, MD Location: Trianon Ballroom, 3rd Floor |
|
3:52 PM - 3:57 PM | Panel Discussion |
END OF SESSION 103 | |
SESSION 104 SCHEDULE | |
Friday
SESSION 104:
MORE DEEP VENOUS OBSTRUCTION, VENA CAVA, AND STENTS
Location: Trianon Ballroom, 3rd Floor
Moderators:Erin H. Murphy, MD / Efthymios (Makis) Avgerinos, MD |
|
x | |
3:58 PM - 4:03 PM | IVC Reconstruction Options |
Presenter(s):Erin H. Murphy, MD Location: Trianon Ballroom, 3rd Floor |
|
4:04 PM - 4:09 PM | Tips And Tricks For Optimal Management Of Primary And Secondary IVC Tumors |
Presenter(s):Jill J. Colglazier, MD Location: Trianon Ballroom, 3rd Floor |
|
4:10 PM - 4:15 PM | Stenting Across The IVC Filter Is A Safe And Effective Alternative To Complex Removal |
Presenter(s):Efthymios (Makis) Avgerinos, MD |
|
4:16 PM - 4:21 PM | Techniques For Open Removal Of Occluded Open And Closed Cell IVC And Iliofemoral Venous Stents |
Presenter(s):Steven D. Abramowitz, MD Location: Trianon Ballroom, 3rd Floor |
|
4:22 PM - 4:27 PM | Popliteal Venous Aneurysm Repair: How And When To Treat |
Presenter(s):Heron E. Rodriguez, MD Location: Trianon Ballroom, 3rd Floor |
|
4:28 PM - 4:33 PM | Effect Of Venoactive Compounds In Post-Thrombotic Syndrome |
Presenter(s):Monika L. Gloviczki, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
4:34 PM - 4:39 PM | Does Reducing Venous Hypertension By Ablation Or Venous Stenting “Cure” Edema In Patients With Venous Ulcers |
Presenter(s):Thomas F. O'Donnell, Jr., MD |
|
4:40 PM - 4:45 PM | Tips And Tricks When Iliac Vein Stenting And Endovenous Ablation Fail To Heal Venous Ulcers |
Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS Location: Trianon Ballroom, 3rd Floor |
|
4:46 PM - 4:51 PM | Getting Out Of A Pinch: A Technique To Remove Frozen Central Venous Catheters |
Presenter(s):Scott L. Stevens, MD Location: Trianon Ballroom, 3rd Floor |
|
4:52 PM - 4:57 PM | Panel Discussion |
END OF SESSION 104 | |
SESSION 105 SCHEDULE | |
Friday
SESSION 105:
MORE IMPORTANT DEEP VENOUS CONCEPTS
|
|
x | |
4:58 PM - 5:03 PM | Thrombolysis For Acute DVT: Guidance From Current Clinical Trials |
Presenter(s):Brian G. DeRubertis, MD Location: Trianon Ballroom, 3rd Floor |
|
5:04 PM - 5:09 PM | Outcomes Of Acute Superior Mesenteric Venous Thrombosis |
Presenter(s):Rabih A. Chaer, MD Location: Trianon Ballroom, 3rd Floor |
|
5:10 PM - 5:15 PM | Measurement Of Edema Using Volumetric Plethysmography |
Presenter(s):Seshadri Raju, MD Location: Trianon Ballroom, 3rd Floor |
|
5:16 PM - 5:21 PM | Open Surgical And Endovascular Treatment Of Superior Vena Cava Syndrome |
Presenter(s):Manju Kalra, MBBS Location: Trianon Ballroom, 3rd Floor |
|
5:22 PM - 5:27 PM | Venous Stent Thrombosis: Insights From The ABRE Study |
Presenter(s):Erin H. Murphy, MD Location: Trianon Ballroom, 3rd Floor |
|
5:28 PM - 5:33 PM | Indications, Technical Aspects, And Outcomes Of Stent Placement In Chronic Iliofemoral Venous Obstruction |
Presenter(s):Maxim Shaydakov, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
5:34 PM - 5:39 PM | NIVL Management: Highlights From VIVA, AVF, AVLS, SCAI Consensus Statement |
Presenter(s):Kush R. Desai, MD Location: Trianon Ballroom, 3rd Floor |
|
5:40 PM - 5:45 PM | Hemodynamic Consequences After Venous Stenting: An In Vitro Assessment |
Presenter(s):Houman Jalaie, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
5:46 PM - 5:51 PM | Suprainguinal Lymphatic Disease In Patients Undergoing Stenting For Chronic Iliofemoral Venous Obstruction |
Presenter(s):Arjun Jayaraj, MD Location: Trianon Ballroom, 3rd Floor |
|
5:52 PM - 5:57 PM | Panel Discussion End of Program M |
END OF SESSION 105 |